Stanford Medicine infectious disease expert Yvonne Maldonado leads calls to ensure children are top of mind in preparing for future pandemics.
Super-talented cellist Josh Roman opens up about how the condition caused him to doubt himself and his music. Now he’s back and sharing his story — at Stanford Medicine and well beyond.
Custom designing proteins — a breakthrough recognized by the latest Nobel Prize in chemistry — could yield treatments that stop the worst of COVID-19 before it begins.
Gianna Nino-Tapias knows the challenges of migrant farmworkers better than most. Her mother continues to pick blueberries daily. She plans to use her medical degree to help integrate and advocate for better health care.
Researchers who study long COVID say its debilitating symptoms are often misdiagnosed by clinicians and dismissed by employers or loved ones because so little is known about the new syndrome.
Nationwide, the percentage of health care visits for flulike symptoms ticked up above the baseline at the start of November and has remained elevated ever since, according to the Centers for Disease Control and Prevention.
The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
Stanford Medicine researchers are designing vaccines that might protect people from not merely individual viral strains but broad ranges of them. The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
Post-Nobel Prize announcement, we're spotlighting the science behind the mRNA-based COVID-19 vaccine and how it may impact medicine broadly.
Stanford Medicine infectious disease expert Anne Liu provides guidance on the RSV, flu and new COVID-19 vaccines this fall.
Scientists explain a key difference between the spike-protein molecules generated by the SARS-CoV-2 mRNA vaccine and those the virus induces.
Researchers at Stanford Medicine have investigated the mechanism of pulmonary fibrosis caused by long COVID.
Researchers at Stanford are devising new ways to deliver mRNA to the body to facilitate more potent and accurate treatments and vaccines.
This is Part I in a series that will explore the promise, challenges and future of mRNA. Let's count our blessings. The COVID-19 pandemic, from …
As the year comes to a close, we're sharing the most-read stories, most-viewed videos and most popular stories on social media of 2022.
